Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey
Generics and Biosimilars Initiative Journal · 15.06.2017 · 6 (2) · 79-88
DOI: 10.5639/gabij.2017.0602.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Generics and Biosimilars Initiative Journal, online erschienen am 15.06.2017. Verfasst von Sabine Vogler und 1 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vogler, S., & Schneider, P. (2017). Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey. Generics and Biosimilars Initiative Journal, 6(2), 79-88. https://doi.org/10.5639/gabij.2017.0602.015
Vancouver
Vogler S, Schneider P. Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey. Generics and Biosimilars Initiative Journal. 2017;6(2):79-88. doi:10.5639/gabij.2017.0602.015
BibTeX
@article{Vogler2017,
author = {Vogler, Sabine and Schneider, Peter},
title = {Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey},
journal = {Generics and Biosimilars Initiative Journal},
year = {2017},
volume = {6},
number = {2},
pages = {79--88},
doi = {10.5639/gabij.2017.0602.015}
}
EUVIMED